
Science Translational Medicine has issued an expression of concern about a 2020 paper on the genetics of colorectal cancer by a group in China whose results were pegged on a test that couldn’t have produced the findings.
The article, “Circulating tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for colorectal cancer,” appeared in January, with authors from both academia and an outfit called the Guangzhou Youze Biological Pharmaceutical Technology Company.
Continue reading Former UCSD prof who resigned amid investigation into China ties has paper flagged for using the wrong test
After a finding of data manipulation, the corresponding author of a 2014 paper by a team of researchers at Indiana University has retracted the work.
Science
Science Translational Medicine has retracted a paper by researchers based in Switzerland, after an investigation concluded two figures had been manipulated.
Despite continuing to vigorously defend their work, the authors of a controversial paper about the effects of human pollution 
When zoologists at the University of Oxford 
In August, Science told us it was